Received Feb 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | BH57H | — |
Print incorrect; product complaint; This non-serious case was reported by a other health professional via call center representative and described the occurrence of product label confusion in a patient who received DTPa (Infanrix) (batch number BH57H, expiry date 07-JUL-2026) for prophylaxis. This case was associated with a product complaint. On an unknown date, the patient received Infanrix. On an unknown date, an unknown time after receiving Infanrix, the patient experienced product label confusion (Verbatim: Print incorrect) and pharmaceutical product complaint (Verbatim: product complaint). The outcome of the product label confusion and pharmaceutical product complaint were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-FEB-2026 The reporter reported that the package denoted use from 6 weeks to 7 years of age, however the package stated 6 weeks through 6 years (prior to the birthday). The reporter reported that no doses had been missed and none had been given outside the age range stated in the package insert.